Shuttle Pharmaceuticals Holdings, Inc.SHPHNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank50
3Y CAGR-82.4%
5Y CAGR-78.8%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-82.4%/yr
Annual compound
5Y CAGR
-78.8%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 2.89% |
| 2023 | 235.80% |
| 2022 | 2.50% |
| 2021 | 531.63% |
| 2020 | 0.00% |
| 2018 | 6747.37% |
| 2017 | 0.00% |